var data={"name":"Scleroderma","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Classification and diagnosis","type":"SUBSECTION","items":[{"name":"Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-differential-diagnosis-of-systemic-sclerosis-scleroderma-in-adults"},{"name":"Eosinophilic fasciitis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=eosinophilic-fasciitis"},{"name":"Overview and classification of scleroderma disorders","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-and-classification-of-scleroderma-disorders"},{"name":"Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-sclerosis-scleroderma-in-adults"}]},{"name":"Eosinophilic fasciitis","type":"SUBSECTION","items":[{"name":"Eosinophilic fasciitis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=eosinophilic-fasciitis"}]},{"name":"Gastrointestinal disease","type":"SUBSECTION","items":[{"name":"Gastrointestinal manifestations of systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gastrointestinal-manifestations-of-systemic-sclerosis-scleroderma"},{"name":"Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-gastrointestinal-disease-in-systemic-sclerosis-scleroderma"}]},{"name":"Lung disease","type":"SUBSECTION","items":[{"name":"Clinical manifestations, evaluation, and diagnosis of interstitial lung disease in systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-evaluation-and-diagnosis-of-interstitial-lung-disease-in-systemic-sclerosis-scleroderma"},{"name":"Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, classification, risk factors, screening, and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pulmonary-arterial-hypertension-in-systemic-sclerosis-scleroderma-definition-classification-risk-factors-screening-and-prognosis"},{"name":"Treatment and prognosis of interstitial lung disease in systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-interstitial-lung-disease-in-systemic-sclerosis-scleroderma"}]},{"name":"Miscellaneous manifestations","type":"SUBSECTION","items":[{"name":"Neuromuscular manifestations of systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neuromuscular-manifestations-of-systemic-sclerosis-scleroderma"}]},{"name":"Overlap syndromes and undifferentiated disease","type":"SUBSECTION","items":[{"name":"Clinical manifestations of mixed connective tissue disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-of-mixed-connective-tissue-disease"},{"name":"Definition and diagnosis of mixed connective tissue disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=definition-and-diagnosis-of-mixed-connective-tissue-disease"},{"name":"Prognosis and treatment of mixed connective tissue disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-and-treatment-of-mixed-connective-tissue-disease"},{"name":"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=undifferentiated-systemic-rheumatic-connective-tissue-diseases-and-overlap-syndromes"}]},{"name":"Pathogenesis","type":"SUBSECTION","items":[{"name":"Pathogenesis of systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-systemic-sclerosis-scleroderma"},{"name":"Pathogenesis of the Raynaud phenomenon","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-the-raynaud-phenomenon"},{"name":"Risk factors for and possible causes of systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risk-factors-for-and-possible-causes-of-systemic-sclerosis-scleroderma"}]},{"name":"Pregnancy","type":"SUBSECTION","items":[{"name":"Systemic sclerosis (scleroderma) and pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-sclerosis-scleroderma-and-pregnancy"}]},{"name":"Raynaud phenomenon","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of the Raynaud phenomenon","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-the-raynaud-phenomenon"},{"name":"Initial treatment of the Raynaud phenomenon","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-treatment-of-the-raynaud-phenomenon"},{"name":"Pathogenesis of the Raynaud phenomenon","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-the-raynaud-phenomenon"},{"name":"Treatment of the Raynaud phenomenon resistant to initial therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-the-raynaud-phenomenon-resistant-to-initial-therapy"}]},{"name":"Renal disease","type":"SUBSECTION","items":[{"name":"Renal disease in systemic sclerosis (scleroderma), including scleroderma renal crisis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=renal-disease-in-systemic-sclerosis-scleroderma-including-scleroderma-renal-crisis"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"General principles of the use of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-the-use-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"Immunomodulatory and antifibrotic approaches to the treatment of systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunomodulatory-and-antifibrotic-approaches-to-the-treatment-of-systemic-sclerosis-scleroderma"},{"name":"Overview of the treatment and prognosis of systemic sclerosis (scleroderma) in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-and-prognosis-of-systemic-sclerosis-scleroderma-in-adults"},{"name":"Preoperative evaluation and perioperative management of patients with rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=preoperative-evaluation-and-perioperative-management-of-patients-with-rheumatic-diseases"},{"name":"Pretreatment evaluation of adults with systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pretreatment-evaluation-of-adults-with-systemic-sclerosis-scleroderma"},{"name":"Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, classification, risk factors, screening, and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pulmonary-arterial-hypertension-in-systemic-sclerosis-scleroderma-definition-classification-risk-factors-screening-and-prognosis"},{"name":"Surgery in patients with systemic sclerosis (scleroderma) of the hand","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=surgery-in-patients-with-systemic-sclerosis-scleroderma-of-the-hand"},{"name":"Treatment and prognosis of interstitial lung disease in systemic sclerosis (scleroderma)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-interstitial-lung-disease-in-systemic-sclerosis-scleroderma"}]}]}